These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33880422)

  • 1. The role of nanotechnology in current COVID-19 outbreak.
    Tavakol S; Zahmatkeshan M; Mohammadinejad R; Mehrzadi S; Joghataei MT; Alavijeh MS; Seifalian A
    Heliyon; 2021 Apr; 7(4):e06841. PubMed ID: 33880422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19.
    Yakoubi A; Dhafer CEB
    Plasmonics; 2023; 18(1):311-347. PubMed ID: 36588744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
    Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF
    J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
    Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology for COVID-19: Therapeutics and Vaccine Research.
    Chauhan G; Madou MJ; Kalra S; Chopra V; Ghosh D; Martinez-Chapa SO
    ACS Nano; 2020 Jul; 14(7):7760-7782. PubMed ID: 32571007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation.
    Singh P; Singh D; Sa P; Mohapatra P; Khuntia A; K Sahoo S
    Nanomedicine (Lond); 2021 Jun; 16(14):1219-1235. PubMed ID: 33998837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of nanomaterials in COVID-19 pandemic.
    Xiao MF; Zeng C; Li SH; Yuan FL
    Rare Metals; 2022; 41(1):1-13. PubMed ID: 34539132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?
    Ranjbar S; Fatahi Y; Atyabi F
    J Drug Deliv Sci Technol; 2022 Jan; 67():102899. PubMed ID: 34630635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform.
    Sa-Nguanmoo N; Namdee K; Khongkow M; Ruktanonchai U; Zhao Y; Liang XJ
    Nano Res; 2022; 15(3):2196-2225. PubMed ID: 34659650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.
    Dube T; Ghosh A; Mishra J; Kompella UB; Panda JJ
    Adv Ther (Weinh); 2021 Feb; 4(2):2000172. PubMed ID: 33173808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication.
    Ramakrishnan SG; Robert B; Salim A; Ananthan P; Sivaramakrishnan M; Subramaniam S; Natesan S; Suresh R; Rajeshkumar G; Maran JP; Al-Dhabi NA; Karuppiah P; Valan Arasu M
    Microb Pathog; 2021 Oct; 159():105133. PubMed ID: 34390768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
    Hassanzadeh P
    J Control Release; 2020 Dec; 328():112-126. PubMed ID: 32882269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight from nanomaterials and nanotechnology towards COVID-19.
    Singh YD; Ningthoujam R; Panda MK; Jena B; Babu PJ; Mishra AK
    Sens Int; 2021; 2():100099. PubMed ID: 34766056
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.